Literature DB >> 10810473

Total hip arthroplasty in young patients. 8- to 13-year results using an uncemented stem.

J R McLaughlin1, K R Lee.   

Abstract

One hundred eight uncemented total hip arthroplasties were performed in 91 patients who were 50 years of age or younger using the Taperloc femoral component. The average age of the patients at time of surgery was 37 years (range, 20-50 years). The mean followup was 10.2 years (range, 8-13 years). No patient was lost to followup. Seven patients (eight hips) died before obtaining the minimum time of 8 years for inclusion in this study. All seven died with their femoral components in place. Of the remaining 100 total hip arthroplasties, no femoral component required revision for aseptic loosening. One femoral component was revised to correct a leg length discrepancy, and one well-fixed femoral component was revised for sepsis. In the 98 total hip arthroplasties that had not undergone femoral component revision, complete radiographic and clinical followup was obtained. Radiographically, 96 (98%) femoral components were determined to have fixation by bone ingrowth, two (2%) femoral components showed stable fibrous ingrowth, and no femoral component was unstable. Femoral cortical osteolysis occurred in seven (7%) hips; major lysis was present in only one (1%). Clinically, 91 (93%) total hip arthroplasties were rated good or excellent; six (6%) were rated fair, and one (1%) was rated poor. Thirty-nine patients with 47 total hip arthroplasties (48%) were engaged in moderate to strenuous manual labor. These results indicate that excellent fixation and minimal lysis can be achieved with an uncemented femoral component in young and active patients at 10 years.

Entities:  

Mesh:

Year:  2000        PMID: 10810473

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  The dimensional accuracy of preparation of femoral cavity in cementless total hip arthroplasty.

Authors:  Li-dong Wu; H J Hahne; J Hassenpflug
Journal:  J Zhejiang Univ Sci       Date:  2004-10

2.  [Five-year results following autogenous osteochondral transplantation to the femoral head].

Authors:  Marcus Rittmeister; K Hochmuth; S Kriener; J Richolt
Journal:  Orthopade       Date:  2005-04       Impact factor: 1.087

3.  [Cementless stems of the hip. Current status].

Authors:  H Effenberger; M Imhof; U Witzel; S Rehart
Journal:  Orthopade       Date:  2005-05       Impact factor: 1.087

Review 4.  [Results for endoprosthetic care in patients younger than 50 years].

Authors:  J Ziegler; M Amlang; M Bottesi; S Kirschner; W-C Witzleb; K-P Günther
Journal:  Orthopade       Date:  2007-04       Impact factor: 1.087

5.  Survivorship of 2000 tapered titanium porous plasma-sprayed femoral components.

Authors:  Adolph V Lombardi; Keith R Berend; Thomas H Mallory; Michael D Skeels; Joanne B Adams
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

6.  Durability of second-generation extensively porous-coated stems in patients age 50 and younger.

Authors:  Jennifer A Moyer; Catherine M Metz; John J Callaghan; David W Hennessy; Steve S Liu
Journal:  Clin Orthop Relat Res       Date:  2009-09-01       Impact factor: 4.176

7.  Early Post-operative Periprosthetic Femur Fracture in the Presence of a Non-cemented Tapered Wedge Femoral Stem.

Authors:  H John Cooper; José A Rodriguez
Journal:  HSS J       Date:  2010-04-02

8.  Hip resurfacing data from national joint registries: what do they tell us? What do they not tell us?

Authors:  Kristoff Corten; Steven J MacDonald
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

9.  Survival of Bi-Metric femoral stems in 77 total hip arthroplasties for juvenile chronic arthritis.

Authors:  C C Lybäck; C O Lybäck; A Kyrö; H J Kautiainen; E A Belt
Journal:  Int Orthop       Date:  2004-08-14       Impact factor: 3.075

10.  Custom cementless stem improves hip function in young patients at 15-year followup.

Authors:  Xavier Flecher; Oliver Pearce; Sebastien Parratte; Jean-Manuel Aubaniac; Jean-Noel Argenson
Journal:  Clin Orthop Relat Res       Date:  2009-08-19       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.